DADarlina Hani Fadil Azim

Darlina Hani Fadil Azim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Darlina Hani Fadil Azim has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • What Is the State of Health Psychology in the Global South?

    by Enoch Teye-Kwadjo, Darlina Hani Fadil Azim, Asma Bibi, Jo Hart

    Despite the growth of health psychology in the Global North, there is a paucity of information on the state of health psychology in the Global South (Dados & Connell, 2012). This chapter aims to fill that gap. We begin by exploring the presence and reach of health psychology as a professional division in the Global South, relying primarily on information provided on the websites of psychology associations/societies, keyword searches on university websites, and the World Wide Web. We then describe the state of health psychology as a professional division in countries of the Global South, from Africa through Asia and the Pacific to Latin America and the Caribbean. Following this, we present information regarding the presence or otherwise of health psychology interest groups or bodies in the Global South. Finally, for each country where health psychology is present, we highlight empirical research that indicates the scope of health psychology topics/themes being addressed. We conclude by noting that despite its relatively young age, health psychology as a professional division seems to be growing faster in the Global South than previously thought and suggest ways in which that growth might be supported.

  • Open Access

    Improving physical and psychological outcomes of cardiac patients using the Naluri app: A study protocol for a randomized controlled trial

    by Darlina H. Fadil Azim, Azmee Mohd Ghazi, Siew Hoon Ong, Hariyati S. Abdul Majid, Karen Morgan, Anne Hickey

    Background: Coronary artery disease (CAD) continues to be a significant burden to public health. Poor treatment and management can lead to more severe cardiac events that could result in death or disability. Early interventions like cardiac rehabilitation programs can provide patients the required knowledge, skills and support to recover from and prevent more cardiac events. Electronic health (eHealth) interventions have potential to complement hospital-based rehabilitation programs. This study aims to investigate the effectiveness of the Naluri app in improving health behaviours, clinical and psychological outcomes in a sample of cardiac patients in Malaysia. Methods: This study is a two-arm, parallel, superiority randomized control trial to be conducted at the Malaysian National Heart Institute. A total of 200 patients will be randomly assigned to either a 16-week theory-based Naluri app in addition to usual care (treatment) or to usual care only (control). Outcomes will be measured at baseline and at 16 weeks. Health behaviour outcomes include physical activity and diet. Clinical outcomes include BMI, hemoglobin A1c (HbA1c), and lipid levels. Psychological outcomes include anxiety, depression, and health related quality of life (HRQOL). The Naluri app theoretical framework is based on the Health Action Process Approach (HAPA) theory. Risk perception, self-efficacy, planning, intentions, outcome expectancies, illness perceptions and psychological outcomes will be measured using self-reported measures. Discussion: This trial will determine the effectiveness of the Naluri app intervention in improving various outcomes of cardiac patients after four months. It will provide data on the applicability of the HAPA theory in Mobile health (mHealth) intervention and the acceptance and efficacy of mHealth as a cardiac rehabilitation program for patients in Malaysia. The results may inform the potential implementation of the app for use with patients with other chronic illnesses like diabetes, stroke, and depression. Registration: Australia New Zealand Clinical Trials Registry (14/01/2019, ACTRN12619000104156).